Ignite Creation Date:
2025-12-24 @ 7:57 PM
Ignite Modification Date:
2025-12-25 @ 5:32 PM
Study NCT ID:
NCT03455504
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-10
First Post:
2018-02-28
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Venetoclax Add in Combination With Fludarabine, Cyratabine and Idarubicine in Induction for Acute Myelid Leukemia
Sponsor:
Gruppo Italiano Malattie EMatologiche dell'Adulto
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-10-26
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-01
Completion Date Type:
ESTIMATED
First Submit Date:
2018-02-28
First Submit QC Date:
None
Study First Post Date:
2018-03-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-09
Last Update Post Date:
2024-04-10
Last Update Post Date Type:
ACTUAL